Chun Chen
Sun Yat-sen University(CN)The Seventh Affiliated Hospital of Sun Yat-sen University(CN)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Esophageal Cancer Research and Treatment, Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes, Cancer-related molecular mechanisms research
Most-Cited Works
- → Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study(2017)524 cited
- → Integrin-α9 Is Required for Fibronectin Matrix Assembly during Lymphatic Valve Morphogenesis(2009)342 cited
- → The α v β 1 integrin plays a critical in vivo role in tissue fibrosis(2015)294 cited
- → Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial(2018)291 cited
- → Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial(2020)269 cited
- → Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 -Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study